Breathe.me

Company Overview

Snapshot

Founded in November 2015 by David Groberman, Tal Slonim, and Rahav Cohen, Breathe.me operates with 1–10 employees. The company has secured funding across one round from two investors. In June 2016, Breathe.me received funding from Sanara Ventures and Israel Innovation Authority.

Business overview

Breathe.me develops a monitoring and management solution for individuals suffering from asthma, COPD, and other respiratory conditions. The company's core technology involves an affordable, entirely mechanical device that attaches to a smartphone, paired with a corresponding app. This system functions like a whistle, generating an acoustic tone recorded by the app, which then uses a proprietary algorithm to analyze the recording and extract spirometric values such as peak flow (PEF) and FEV1. The Breathe.me app also includes a disease-management diary for tracking measurement results, symptoms, and medication usage, aiming to integrate into clinical platforms and provide personalized actionable insights. It operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and medical devices, particularly in patient remote monitoring and medical monitors.

Company Intelligence Q&A

What is Breathe.me's primary focus?

Breathe.me focuses on providing a monitoring and management solution for individuals with asthma, COPD, and other respiratory conditions, enabling lung-function monitoring and self-management.

When was Breathe.me founded?

Breathe.me was founded in November 2015.

Who are the founders of Breathe.me?

Breathe.me was founded by David Groberman, Tal Slonim, and Rahav Cohen.

What is the status of Breathe.me?

Breathe.me is currently non-active, having ceased to operate in June 2021.

What type of product does Breathe.me offer?

Breathe.me offers a product called Peak.me, which is a mechanical device that attaches to a smartphone and works with an app to monitor respiratory health.